A multicenter, non-randomized, open-label observational study to assess effectiveness of indacaterol as measured by patient reported outcomes in COPD patients in real life settings - INFLOW
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Indacaterol (Primary) ; Indacaterol (Primary) ; Formoterol; Salmeterol; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms INFLOW
- Sponsors Novartis
- 12 Dec 2013 New trial record